Literature DB >> 22239032

Rapid and sensitive detection of Shiga toxin-producing Escherichia coli directly from stool samples by real-time PCR in comparison to culture, enzyme immunoassay and Vero cell cytotoxicity assay.

Andreas Gerritzen1, Johann-Wolfgang Wittke, Dietmar Wolff.   

Abstract

BACKGROUND: From May until July 2011 a large outbreak of infections with Shiga toxin (Stx)-producing Escherichia coli (STEC) occurred in Germany. More than 800 patients suffered from hemolytic uremic syndrome (HUS), and 49 fatal cases were reported. Obviously, a mandatory requirement for such a clinical situation is the availability of rapid and reliable STEC tests from the investigating laboratory. The standard methods like enzyme immunoassay (EIA), vero cell cytotoxicity assay (VCA), and microbiological culture are, however, hampered by a lack of sensitivity and specificity unless a prior, time consuming broth enrichment step is employed. In order to acelerate the laboratory diagnosis, we evaluated an in-house real-time PCR assay for the detection of the Stx genes (stx1 and stx2) directly from stool specimens without the need of broth enrichment procedures.
METHODS: 754 faecal samples were collected from 481 predominantly hospitalised patients with diarrhea from May 23 to June 10, 2011 at the Medical Laboratory Bremen, Germany. The samples were analysed with a direct stx real-time PCR and compared to EIA, VCA and culturing on enterohemolysin, ESBL, and CPS agar after broth enrichment. In addition, artificial samples (n = 12) from three official EHEC/STEC PCR quality proficiency panels (INSTAND, Germany, September 2006, September 2007, and April 2008) were analysed by real-time PCR only.
RESULTS: The real-time PCR produced reliable, distinct melting profiles with characteristic peaks for the stx1 and stx2 PCR products. The quality proficiency panels revealed a detection limit of 10 CFU/PCR per reaction. 112, 86, 99, and 122 of 754 clinical samples were positive for culture, EIA, VCA, and real-time PCR, respectively. 121 of 122 PCR samples were positive only for stx2. Compared to culture as the gold standard, sensitivities of EIA, VCA, and real-time PCR were 76.8 %, 83.9%, and 96.4% and specificities were 99.4%, 99.2%, and 97.8%, respectively.
CONCLUSIONS: The direct fecal stx real-time PCR proved superior to enrichment based VCA and EIA and can be recommended as a quick and sensitive tool for the early diagnosis of STEC infection in addition to microbiological culture.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22239032

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  11 in total

1.  A Couple's Colitis.

Authors:  David Phillip Serota; Stephanie Halvorson; Sima Desai
Journal:  J Gen Intern Med       Date:  2015-03-31       Impact factor: 5.128

2.  Genome Sequence Analysis and Characterization of Shiga Toxin 2 Production by Escherichia coli O157:H7 Strains Associated With a Laboratory Infection.

Authors:  Mark Eppinger; Sonia Almería; Anna Allué-Guardia; Lori K Bagi; Anwar A Kalalah; Joshua B Gurtler; Pina M Fratamico
Journal:  Front Cell Infect Microbiol       Date:  2022-06-13       Impact factor: 6.073

3.  Enteroaggregative Escherichia coli quantification in children stool samples using quantitative PCR.

Authors:  Ila Fernanda Nunes Lima; Josiane da Silva Quetz; Richard Littleton Guerrant; James P Nataro; Eric R Houpt; Aldo Angelo Moreira Lima; Alexandre Havt
Journal:  APMIS       Date:  2012-12-06       Impact factor: 3.205

Review 4.  Management of hemolytic uremic syndrome.

Authors:  David Kavanagh; Shreya Raman; Neil S Sheerin
Journal:  F1000Prime Rep       Date:  2014-12-01

Review 5.  Public Health Research Resulting from One of the World's Largest Outbreaks Caused by Entero-Hemorrhagic Escherichia coli in Germany 2011: A Review.

Authors:  Elena Köckerling; Laura Karrasch; Aparna Schweitzer; Oliver Razum; Gérard Krause
Journal:  Front Public Health       Date:  2017-12-11

6.  Shigella sonnei and hemolytic uremic syndrome: A case report and literature review.

Authors:  Casey Adams; Aaron Vose; Michael B Edmond; Laurel Lyckholm
Journal:  IDCases       Date:  2017-02-10

7.  Performance of commercial tests for molecular detection of Shiga toxin-producing Escherichia coli (STEC): a systematic review and meta-analysis protocol.

Authors:  Gillian A M Tarr; Chu Yang Lin; Diane Lorenzetti; Linda Chui; Phillip I Tarr; Lisa Hartling; Ben Vandermeer; Stephen B Freedman
Journal:  BMJ Open       Date:  2019-03-07       Impact factor: 2.692

8.  Leveraging 16S rRNA Microbiome Sequencing Data to Identify Bacterial Signatures for Irritable Bowel Syndrome.

Authors:  Yuxia Liu; Wenhui Li; Hongxia Yang; Xiaoying Zhang; Wenxiu Wang; Sitong Jia; Beibei Xiang; Yi Wang; Lin Miao; Han Zhang; Lin Wang; Yujing Wang; Jixiang Song; Yingjie Sun; Lijuan Chai; Xiaoxuan Tian
Journal:  Front Cell Infect Microbiol       Date:  2021-06-11       Impact factor: 5.293

9.  Interaction between Shiga toxin and monoclonal antibodies: binding characteristics and in vitro neutralizing abilities.

Authors:  Letícia B Rocha; Daniela E Luz; Claudia T P Moraes; Andressa Caravelli; Irene Fernandes; Beatriz E C Guth; Denise S P Q Horton; Roxane M F Piazza
Journal:  Toxins (Basel)       Date:  2012-09-18       Impact factor: 4.546

Review 10.  Detection, Characterization, and Typing of Shiga Toxin-Producing Escherichia coli.

Authors:  Brendon D Parsons; Nathan Zelyas; Byron M Berenger; Linda Chui
Journal:  Front Microbiol       Date:  2016-04-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.